Jenifer H Voeks1, George Howard1, Gary Roubin1, Richard Farb1, Donald Heck1, William Logan1, Mary Longbottom1, Alice Sheffet1, James F Meschia1, Thomas G Brott2. 1. From the Department of Neurology, Medical University of South Carolina, Charleston (J.H.V.); Department of Biostatistics, University of Alabama at Birmingham (G.H.); Cardiovascular Associates of the Southeast, Birmingham, AL (G.R.); Division of Neuroradiology, Department of Medical Imaging, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada (R.F.); Department of Radiology, Novant Health Forsyth Medical Center, Winston-Salem, NC (D.H.); Mercy Clinic Neurology, Mercy Hospital, St. Louis, MO (W.L.); Department of Neurology, Mayo Clinic, Jacksonville, FL (M.L., J.F.M., T.G.B.); and Department of Surgery, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark (A.S., T.G.B.). 2. From the Department of Neurology, Medical University of South Carolina, Charleston (J.H.V.); Department of Biostatistics, University of Alabama at Birmingham (G.H.); Cardiovascular Associates of the Southeast, Birmingham, AL (G.R.); Division of Neuroradiology, Department of Medical Imaging, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada (R.F.); Department of Radiology, Novant Health Forsyth Medical Center, Winston-Salem, NC (D.H.); Mercy Clinic Neurology, Mercy Hospital, St. Louis, MO (W.L.); Department of Neurology, Mayo Clinic, Jacksonville, FL (M.L., J.F.M., T.G.B.); and Department of Surgery, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark (A.S., T.G.B.). Brott.Thomas@mayo.edu.
Abstract
BACKGROUND AND PURPOSE: There is higher combined risk of stroke or death (S+D) at older ages with carotid stenting. We assess whether this can be attributed to patient or arterial characteristics that are in the pathway between older age and higher risk. METHODS: Mediation analysis of selected patient (hypertension, diabetes mellitus, and dyslipidemia) and arterial characteristics assessed at the clinical sites and the core laboratory (plaque length, eccentric plaque, ulcerated plaque, percent stenosis, peak systolic velocity, and location) was performed in 1123 carotid artery stenting-treated patients in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). We assessed the association of age with these characteristics, the association of these characteristics with stroke risk, and the amount of mediation of the association of age on the combined risk of periprocedural S+D with adjustment for these factors. RESULTS: Only plaque length as measured at the sites increased with age, was associated with increased S+D risk and significantly mediated the association of age on S+D risk. However, adjustment for plaque length attenuated the increased risk per 10 years of age from 1.72 (95% confidence interval, 1.26-2.37) to 1.66 (95% confidence interval, 1.20-2.29), accounting for only 8% of the increased risk. CONCLUSIONS:Plaque length seems to be in the pathway between older age and higher risk of S+D among carotid artery stenting-treated patients, but it mediated only 8% of the age effect excess risk of carotid artery stenting in CREST. Other factors and mechanisms underlying the age effect need to be identified as plaque length will not identify elderly patients for whom stenting is safe relative to endarterectomy. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00004732.
RCT Entities:
BACKGROUND AND PURPOSE: There is higher combined risk of stroke or death (S+D) at older ages with carotid stenting. We assess whether this can be attributed to patient or arterial characteristics that are in the pathway between older age and higher risk. METHODS: Mediation analysis of selected patient (hypertension, diabetes mellitus, and dyslipidemia) and arterial characteristics assessed at the clinical sites and the core laboratory (plaque length, eccentric plaque, ulcerated plaque, percent stenosis, peak systolic velocity, and location) was performed in 1123 carotid artery stenting-treated patients in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST). We assessed the association of age with these characteristics, the association of these characteristics with stroke risk, and the amount of mediation of the association of age on the combined risk of periprocedural S+D with adjustment for these factors. RESULTS: Only plaque length as measured at the sites increased with age, was associated with increased S+D risk and significantly mediated the association of age on S+D risk. However, adjustment for plaque length attenuated the increased risk per 10 years of age from 1.72 (95% confidence interval, 1.26-2.37) to 1.66 (95% confidence interval, 1.20-2.29), accounting for only 8% of the increased risk. CONCLUSIONS: Plaque length seems to be in the pathway between older age and higher risk of S+D among carotid artery stenting-treated patients, but it mediated only 8% of the age effect excess risk of carotid artery stenting in CREST. Other factors and mechanisms underlying the age effect need to be identified as plaque length will not identify elderly patients for whom stenting is safe relative to endarterectomy. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00004732.
Authors: Hans-Henning Eckstein; Peter Ringleb; Jens-Rainer Allenberg; Jürgen Berger; Gustav Fraedrich; Werner Hacke; Michael Hennerici; Robert Stingele; Jens Fiehler; Hermann Zeumer; Olav Jansen Journal: Lancet Neurol Date: 2008-09-05 Impact factor: 44.182
Authors: Jenifer H Voeks; George Howard; Gary S Roubin; Mahmoud B Malas; David J Cohen; W Charles Sternbergh; Herbert D Aronow; Mark K Eskandari; Alice J Sheffet; Brajesh K Lal; James F Meschia; Thomas G Brott Journal: Stroke Date: 2011-10-06 Impact factor: 7.914
Authors: Leo H Bonati; Joanna Dobson; Ale Algra; Alain Branchereau; Gilles Chatellier; Gustav Fraedrich; Willem P Mali; Hermann Zeumer; Martin M Brown; Jean-Louis Mas; Peter A Ringleb Journal: Lancet Date: 2010-09-15 Impact factor: 79.321
Authors: A J Sheffet; G Roubin; G Howard; V Howard; W Moore; J F Meschia; R W Hobson; T G Brott Journal: Int J Stroke Date: 2010-02 Impact factor: 5.266
Authors: Robert Stingele; Jürgen Berger; Karsten Alfke; Hans-Henning Eckstein; Gustav Fraedrich; Jens Allenberg; Marius Hartmann; Peter A Ringleb; Jens Fiehler; H Bruckmann; M Hennerici; O Jansen; G Klein; A Kunze; P Marx; K Niederkorn; W Schmiedt; L Solymosi; H Zeumer; W Hacke Journal: Lancet Neurol Date: 2008-01-31 Impact factor: 44.182
Authors: Jörg Ederle; Indran Davagnanam; H Bart van der Worp; Graham S Venables; Philippe A Lyrer; Roland L Featherstone; Martin M Brown; H Rolf Jäger Journal: Lancet Neurol Date: 2013-07-12 Impact factor: 44.182
Authors: Leo H Bonati; Jörg Ederle; Joanna Dobson; Stefan Engelter; Roland L Featherstone; Peter A Gaines; Jonathan D Beard; Graham S Venables; Hugh S Markus; Andrew Clifton; Peter Sandercock; Martin M Brown Journal: Int J Stroke Date: 2013-07-29 Impact factor: 5.266